Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Probi AB (publ)
  6. News
  7. Summary
    PROB   SE0001280355

PROBI AB (PUBL)

(PROB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Probi : Presentation of Probi's Q3 report

10/19/2020 | 06:01am EDT

Probi's report for the third quarter 2020 will be published on Wednesday, 21 October at 8.00 a.m. CET.

In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CEO Tom Rönnlund and CFO Henrik Lundkvist will present and comment on the report. The presentation and presentation material can be obtained via www.probi.com (http://www.probi.se) or https://tv.streamfabriken.com/probi-q3-2020

The presentation can also be followed via a telephone conference on the following telephone number:
Sweden: +46 8 50 55 83 68
UK: +44 33 33 00 92 67
US: +1 83 35 26 83 81

After the presentation, conference participants will be able to ask questions. Questions can also be asked via the audiocast.

An on-demand version of the presentation will be available at the address given above following the presentation.

FOR FURTHER INFORMATION, CONTACT:
Henrik Lundkvist, CFO, Probi, tel +46 46 286 89 41, e-post: henrik.lundkvist@probi.com

ABOUT PROBI
Probi AB is a Swedish publicly traded bioengineering company. Probi's vision is to help people live healthier lives by delivering effective and well-documented probiotics, with proven health benefits based on scientific research. Founded by scientists in Sweden in 1991, Probi is a multinational company, active in more than 40 markets around the world and holding over 400 patents worldwide. In 2019, Probi had net sales of MSEK 626. The Probi share is listed on Nasdaq Stockholm, Mid Cap. Probi had about 4,000 shareholders on December 31, 2019. Read more at www.probi.com.

https://news.cision.com/probi/r/presentation-of-probi-s-q3-report,c3218191

https://mb.cision.com/Main/1556/3218191/1320661.pdf

(c) 2020 Cision. All rights reserved., source Press Releases - English

Stocks mentioned in the article
ChangeLast1st jan.
PROBI AB (PUBL) 9.64% 580 Delayed Quote.25.36%
SYMRISE AG 0.93% 114.45 Delayed Quote.4.61%
All news about PROBI AB (PUBL)
06/15PROBIá : and Oriflame enter partnership for digestive...
PU
06/15PROBIá : and Oriflame enter partnership for digestive probiotic concept launch
AQ
05/31PROBIá : Improved probiotic products for women's health - an unmet market need
AQ
05/31PROBIá : Change in the number of shares and votes in Probi
AQ
05/31PROBIá : Improved probiotic products for women's health – an unmet...
PU
05/10PROBI AB (PUBL) : Ex-dividend day for final dividend
FA
05/07PROBIá : Annual General Meeting 2021
AQ
04/23Q1 2021 : Good growth in the first quarter
AQ
04/22PROBIá : and China National Pharmaceutical Foreign Trade Corporation have signed..
AQ
04/21PROBIá : Iron status in healthy pregnant women improved by the probiotic Probi F..
AQ
More news
Financials
Sales 2021 758 M 89,8 M 89,8 M
Net income 2021 119 M 14,1 M 14,1 M
Net cash 2021 318 M 37,7 M 37,7 M
P/E ratio 2021 55,7x
Yield 2021 0,28%
Capitalization 6 609 M 790 M 783 M
EV / Sales 2021 8,30x
EV / Sales 2022 7,24x
Nbr of Employees -
Free-Float 36,5%
Chart PROBI AB (PUBL)
Duration : Period :
Probi AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROBI AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 2
Average target price 505,00 SEK
Last Close Price 580,00 SEK
Spread / Highest target -12,9%
Spread / Average Target -12,9%
Spread / Lowest Target -12,9%
EPS Revisions
Managers and Directors
NameTitle
Tom Juhani R÷nnlund Chief Executive Officer
Henrik Lundkvist Chief Financial Officer
Jean-Yves Parisot Chairman
Niklas Brandt Vice President-Information Technology
Niklas Larsson Lead Scientific Affairs
Sector and Competitors
1st jan.Capitalization (M$)
PROBI AB (PUBL)25.36%724
NESTLÉ S.A.9.92%359 351
MONDELEZ INTERNATIONAL, INC.8.88%91 206
YIHAI KERRY ARAWANA HOLDINGS CO., LTD-19.91%78 024
THE KRAFT HEINZ COMPANY23.37%52 302
DANONE10.31%46 802